Paroxetine hydrochloride and Red cell distribution width increased - a phase IV clinical study of FDA data
Summary:
Red cell distribution width increased is reported as a side effect among people who take Paroxetine hydrochloride (paroxetine hydrochloride), especially for people who are female, 20-29 old, also take Remicade, and have Acne cystic.
The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Paroxetine hydrochloride. It is created by eHealthMe based on reports of 9,481 people who have side effects when taking Paroxetine hydrochloride from the FDA, and is updated regularly.
What is Paroxetine hydrochloride?
Paroxetine hydrochloride has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 10,426 Paroxetine hydrochloride users. Check the latest studies of Paroxetine hydrochloride.
What is Red cell distribution width increased?
Red cell distribution width increased is found to be associated with 606 drugs and 656 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.
9,481 people reported to have side effects when taking Paroxetine hydrochloride.
Among them, 18 people (0.19%) have Red cell distribution width increased.

Among these 18 people:
What is the gender of people who have Red cell distribution width increased when taking Paroxetine hydrochloride? *
- female: 94.44 %
- male: 5.56 %
What is the age of people who have Red cell distribution width increased when taking Paroxetine hydrochloride? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 72.22 %
- 30-39: 16.67 %
- 40-49: 0.0 %
- 50-59: 5.56 %
- 60+: 5.56 %
What are other drugs people take besides Paroxetine hydrochloride? *
- Accutane: 13 people, 72.22%
- Humira: 13 people, 72.22%
- Vitamin B12: 13 people, 72.22%
- Remicade: 13 people, 72.22%
- Acyclovir: 3 people, 16.67%
- Ativan: 3 people, 16.67%
- Benadryl: 3 people, 16.67%
- Cimetidine: 3 people, 16.67%
- Cod Liver Oil: 3 people, 16.67%
- Paroxetine: 3 people, 16.67%
What are other side effects people have besides Red cell distribution width increased? *
- Fatigue (feeling of tiredness): 17 people, 94.44%
- White Blood Cell Count Increased: 16 people, 88.89%
- Arrhythmias (irregular heartbeat): 16 people, 88.89%
- Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 16 people, 88.89%
- Monocyte Count Increased: 15 people, 83.33%
- Cough: 14 people, 77.78%
- Drug Ineffective: 14 people, 77.78%
- Hypoaesthesia (reduced sense of touch or sensation): 14 people, 77.78%
- Haemoglobin Decreased: 14 people, 77.78%
- High Blood Cholesterol: 13 people, 72.22%
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 13 people, 72.22%
- Acne Cystic (skin problems that cause pimples): 13 people, 72.22%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
- Type 2 Diabetes: 3 people, 16.67%
- Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 16.67%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 16.67%
- Panic Disorder: 3 people, 16.67%
- High Blood Cholesterol: 3 people, 16.67%
- Pain: 1 person, 5.56%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Paroxetine hydrochloride and have Red cell distribution width increased?
- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Paroxetine hydrochloride:
- Paroxetine hydrochloride (10,426 reports)
Red cell distribution width increased treatments and more:
- Red cell distribution width increased (5,525 reports)
How severe was Red cell distribution width increased and when was it recovered:
Expand to all the drugs that have ingredients of paroxetine hydrochloride:
- Red cell distribution width increased and drugs with ingredients of paroxetine hydrochloride (87 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Paroxetine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Red cell distribution width increased:
- Red cell distribution width increased (606 drugs)
Browse all the conditions that are associated with Red cell distribution width increased:
- Red cell distribution width increased (656 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on paroxetine hydrochloride (the active ingredients of Paroxetine hydrochloride) and Paroxetine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prednisone and Painful Chest for Women aged 60+ - 4 seconds ago
- Prednisone and Chest Tightness for Women aged 60+ - 4 seconds ago
- Prednisone and Chest Tightness Or Pressure for Women aged 60+ - 4 seconds ago
- Prednisone and Chest Discomfort for Women aged 60+ - 5 seconds ago
- Prednisone and Chest Pain for Women aged 60+ - 5 seconds ago
- Could Firazyr cause Swelling? - 10 seconds ago
- Could Naproxen cause Arterial Occlusive Disease? - 11 seconds ago
- Drug interactions of Imodium and Daliresp - 13 seconds ago
- Drug interactions of Apresoline and Simvastatin - 20 seconds ago
- Drug interactions of Zoloft and Adalat - 26 seconds ago